Download original image
Fig. 3.
Overall survival of studied cases as classified by their phenotypic pattern. The median survival time of patients with the CD34+CD38-CD58- phenotype was 15 months (95% CI, 11–25 mo); the median survival for other phenotypes was not reached.
Blood Res 2018;53:138~144
https://doi.org/10.5045/br.2018.53.2.138
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by
INFOrang Co., Ltd